SB 366791 from Tocris Bioscience, a Bio-Techne Brand

Sizes Available: 10 mg (also 50 mg)

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956
Fax: 1 (612) 656-4400

(2) The Cancer Chemotherapeutic Paclitaxel Increases Human and Rodent Sensory Neuron Responses to TRPV1 by Activation of TLR4The Journal of neuroscience : the official journal of the Society for NeuroscienceSeptember 30, 2015Li Y, Adamek P, Zhang H, Tatsui CE, Rhines LD, Mrozkova P, Li Q, Kosturakis AK, Cassidy RM, Harrison DS, et al.

(3) Innervation of enteric mast cells by primary spinal afferents in guinea pig and human small intestineAmerican journal of physiology. Gastrointestinal and liver physiologyOctober 1, 2014Wang GD, Wang XY, Liu S, Qu M, Xia Y, Needleman BJ, Mikami DJ, Wood JD.

(4) Transient receptor potential vanilloid type 1 channel may modulate opioid rewardNeuropsychopharmacology : official publication of the American College of NeuropsychopharmacologySeptember 1, 2014Nguyen TL, Kwon SH, Hong SI, Ma SX, Jung YH, Hwang JY, Kim HC, Lee SY, Jang CG.

(5) Pharmacodynamics of TRPV1 agonists in a bioassay using human PC-3 cellsTheScientificWorldJournalJanuary 1, 2014Alvarez-Berdugo D, Jiménez M, Clavé P, Rofes L.

(6) Epidermal keratinocyte polarity and motility require Ca²⁺ influx through TRPV1Journal of cell scienceOctober 15, 2013Graham DM, Huang L, Robinson KR, Messerli MA.

(7) Functional expression of purinergic P2 receptors and transient receptor potential channels by the human urotheliumAmerican journal of physiology. Renal physiologyAugust 1, 2013Shabir S, Cross W, Kirkwood LA, Pearson JF, Appleby PA, Walker D, Eardley I, Southgate J.

(9) Opposing roles for cannabinoid receptor type-1 (CB₁) and transient receptor potential vanilloid type-1 channel (TRPV1) on the modulation of panic-like responses in ratsNeuropsychopharmacology : official publication of the American College of NeuropsychopharmacologyJanuary 1, 2012Casarotto PC, Terzian AL, Aguiar DC, Zangrossi H, Guimarães FS, Wotjak CT, Moreira FA.

(12) Paradoxical effects of the cannabinoid CB2 receptor agonist GW405833 on rat osteoarthritic knee joint painOsteoarthritis and cartilageNovember 1, 2010Schuelert N, Zhang C, Mogg AJ, Broad LM, Hepburn DL, Nisenbaum ES, Johnson MP, McDougall JJ.

(14) AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic propertiesThe Journal of pharmacology and experimental therapeuticsApril 1, 2005Gavva NR, Tamir R, Qu Y, Klionsky L, Zhang TJ, Immke D, Wang J, Zhu D, Vanderah TW, Porreca F, et al.

(15) Cannabinoid receptor-independent actions of the aminoalkylindole WIN 55,212-2 on trigeminal sensory neuronsBritish journal of pharmacologyMay 1, 2004Price TJ, Patwardhan A, Akopian AN, Hargreaves KM, Flores CM.

SB 366791